National Aspergillosis Centre - INCAS trial
@nacincas
INCAS is a Phase2 RCT (NCT05653193): adjunctive interferon gamma to treat chronic pulmonary aspergillosis
Based at @MFT_NAC (@MFTnhs), funded by @NIHRresearch
ID: 1573224275502370819
23-09-2022 08:14:41
114 Tweet
51 Followers
177 Following
When the immune system detects #Aspergillus mould, Th1 cells release cytokines (e.g. IFNγ) that stimulate macrophages to fight the #Infection Read more in this great review by Shankar et al (2024 Journal of Fungi MDPI) ➡️ bit.ly/4bGM5GO #IDtwitter #immunology #MedEd #respiratory
